"ROC Curve" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli.
| Descriptor ID |
D012372
|
| MeSH Number(s) |
E05.318.740.872.750 E05.318.780.800.750 N05.715.360.780.700.680 N06.850.520.445.800.750
|
| Concept/Terms |
ROC Curve- ROC Curve
- Curve, ROC
- Curves, ROC
- ROC Curves
- Analysis, ROC
- Analyses, ROC
- ROC Analyses
- ROC Analysis
Receiver Operating Characteristic- Receiver Operating Characteristic
- Characteristic, Receiver Operating
- Characteristics, Receiver Operating
- Receiver Operating Characteristics
|
Below are MeSH descriptors whose meaning is more general than "ROC Curve".
Below are MeSH descriptors whose meaning is more specific than "ROC Curve".
This graph shows the total number of publications written about "ROC Curve" by people in this website by year, and whether "ROC Curve" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 2 | 2 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "ROC Curve" by people in Profiles.
-
Circulating cell-free DNA variables as marker of ovarian cancer patients: A pilot study. Cancer Biomark. 2020; 28(2):159-167.
-
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer. Sci Rep. 2019 02 19; 9(1):2318.
-
Systematic analysis of parameters predicting pathological axillary status (ypN0 vs. ypN+) in patients with breast cancer converting from cN+ to ycN0 through primary systemic therapy (PST). Clin Exp Metastasis. 2018 12; 35(8):777-783.
-
Screening and identification of lncRNAs as potential biomarkers for pulmonary tuberculosis. Sci Rep. 2017 12 01; 7(1):16751.
-
DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA. Oncotarget. 2016 Sep 27; 7(39):64191-64202.
-
Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties. Hepatology. 2015 Sep; 62(3):726-36.
-
Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis. Breast Cancer Res Treat. 2014 Jul; 146(1):163-74.
-
The potential of novel biomarkers to improve risk prediction of type 2 diabetes. Diabetologia. 2014 Jan; 57(1):16-29.
-
Large-scale de novo prediction of physical protein-protein association. Mol Cell Proteomics. 2011 Nov; 10(11):M111.010629.
-
Accurate statistics for local sequence alignment with position-dependent scoring by rare-event sampling. BMC Bioinformatics. 2011 Feb 03; 12:47.
MeSH information
